Hostname: page-component-669899f699-chc8l Total loading time: 0 Render date: 2025-05-07T02:41:43.709Z Has data issue: false hasContentIssue false
  • English
  • Français

Bradyphrenia in parkinsonism: a historical review

Published online by Cambridge University Press:  09 July 2009

Daniel Rogers
Daniel Rogers*
Affiliation:
Department of Neuropsychiatry, Institute of Neurology, London
*
1Address for correspondence: Dr Daniel Rogers,Department of Neuropsychiatry,Institute of Neurology, Queen Square, London WC1N 3BG.
Get access Rights & Permissions [Opens in a new window]

Synopsis

The development over the last 60 years of the concept of bradyphrenia, a syndrome including slowing of cognitive processing in parkinsonism, is described. Psychic akinesia and subcortical dementia are seen as more recent synonyms for this syndrome. Its relations to akinesia and the psychomotor retardation of depression are considered in a historical context, as are its implications for the relation of neurological and psychiatric disorder.

Type
Research Article
Information
Psychological Medicine , Volume 16 , Issue 2 , May 1986 , pp. 257 - 265
Copyright
Copyright © Cambridge University Press 1986

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

References

Agid, Y., Ruberg, M., Dubois, B. & Javoy-Agid, F. (1984). Biochemical substrates of mental disturbances in Parkinson's disease. In Advances in Neurology, Vol. 40 (ed. Hassler, R. G. and Christ, J. F.), pp. 211–218. Raven Press: New York.Google Scholar
Ajuriaguerra, J. de (1971 a). Étude psychopathologique des Parkinsoniens. In Monoamines, noyaux gris centraux et syndrome de Parkinson (ed. de Ajuriaguerra, J. and Gauthier, G.), pp. 327–351. Georg: Geneva.Google Scholar
Ajuriaguerra, J. de (1971 b). La notion d'akinesie. In Monoamines, noyaux gris centraux et syndrome de Parkinson (ed. de Ajuriaguerra, J. and Gauthier, G.), pp. 565–579. Georg: Geneva.Google Scholar
Albert, M. L. (1978). Subcortical dementia. In Alzheimer's Disease, Senile Dementia and Related Disorders (Aging No. 17) (ed. Katzman, R., Terry, R. D. and Bick, K. L.), pp. 173–180. Raven Press: New York.Google Scholar
Albert, M. L., Feldman, R. G. & Willis, A. L. (1974). The ‘subcortical dementia’ of progressive supranuclear palsy. Journal of Neurology, Neurosurgery and Psychiatry 37, 121–130.CrossRefGoogle ScholarPubMed
Anderson, J., Aabro, E., Gulmann, N., Hjelmsted, A. & Pederson, H. E. (1980). Antidepressive treatment in Parkinson's disease. A controlled trial of the effect of nortriptyline in patients with Parkinson's disease treated with L-dopa. Acta Neurologica Scandinavica 62, 210–219.CrossRefGoogle Scholar
Angel, R. W., Alston, W. & Higgins, J. R. (1970). Control of movement in Parkinson's disease. Brain 93, 1–14.CrossRefGoogle ScholarPubMed
Asnis, C. (1977). Parkinson's disease, depression and ECT: a review and case study. American Journal of Psychiatry 134, 191–195.Google ScholarPubMed
Aubrun, W. (1937). Responses aux émotions-chocs chez les parkinsoniens. Année Psychologique 37, 140–171.CrossRefGoogle Scholar
Barbeau, A. (1972). Dopamine and mental function. In L-dopa and Behaviour (ed. Malitz, S.), pp. 9–33. Raven Press: New York.Google Scholar
Booth, G. (1948). Psychodynamics in Parkinsonism, Psychosomatic Medicine 10, 1–14.CrossRefGoogle ScholarPubMed
Brown, G. L. & Wilson, W. P. (1972). Parkinsonism and depression. Southern Medical Journal 65, 540–545.CrossRefGoogle ScholarPubMed
Brown, R. G., Marsden, C. D., Quinn, N. & Wyke, M. A. (1984). Alterations in cognitive performance and affect-arousal state during fluctuations in motor function in Parkinson's disease. Journal of Neurology, Neurosurgery and Psychiatry 47, 454–465.CrossRefGoogle ScholarPubMed
Brumlik, J. & Boshes, B. (1966). The mechanism of bradykinesia in parkinsonism. Neurology 16, 337–344.CrossRefGoogle ScholarPubMed
Celesia, G. G. & Wanamaker, W. M. (1972). Psychiatric disturbances in Parkinson's disease. Diseases of the Nervous System 33, 577–582.Google ScholarPubMed
Cloake, P. C. (1925). Discussion on the mental sequelae of encephalitis lethargica. Proceedings of the Royal Society of Medicine 18, Joint discussion No. 2, pp. 26–31, 37–38.Google Scholar
Delis, D., Direnfeld, L., Alexander, M. P. & Kaplan, E. (1982). Cognitive fluctuations associated with on-off phenomena in Parkinson's disease. Neurology 32, 1049–1052.CrossRefGoogle Scholar
Drachman, D. A. & Stahl, S. (1975). Extrapyramidal dementia and levodopa. Lancet i, 809.CrossRefGoogle Scholar
Economo, C. von (1931). Encephalitis Lethargica, its Sequelae and Treatment (transl. Newman, K. O.). Oxford University Press: London.Google Scholar
Evarts, E. V., Teravainen, H. & Calne, D. B. (1981). Reaction time in Parkinson's disease. Brain 104, 167–186.CrossRefGoogle ScholarPubMed
Garron, D. C., Klawans, H. L. & Narin, F. J. (1972). Intellectual functioning of persons with idiopathic parkinsonism. Journal of Nervous and Mental Disease 154, 445–452.CrossRefGoogle ScholarPubMed
Goodwin, F. K., Brodie, H. K., Murphy, D. L. & Bunney, W. E. (1970). Administration of a peripheral decarboxylase inhibitor with L-dopa to depressed patients. Lancet i, 908–911.CrossRefGoogle Scholar
Hansch, E. C., Syndulko, K., Cohen, S. N., Goldberg, Z. I., Potvin, A. R. & Tourtellote, W. W. (1982). Cognition in Parkinson's disease: an event-related potential perspective. Annals of Neurology 11, 599–607.CrossRefGoogle ScholarPubMed
Hassler, R. (1953). Extrapyramidal-motorische Systeme and Erkrankungen. In Handbuch der innerin Medezin, Vol. 3, pp. 676–904. Springer: Berlin.Google Scholar
Hassler, R. (1965) Extrapyramidal control of the speed of behaviour and its change by primary age processes. In Behaviour, Aging and the Nervous System (ed. Welford, A. T. and Birren, J. E.), pp. 284–306. C. C. Thomas: Springfield, Ill.Google Scholar
Hicks, L. H. & Birren, J. E. (1970). Aging, brain damage, and psychomotor slowing. Psychological Bulletin 74, 377–396.CrossRefGoogle ScholarPubMed
Horn, S. (1974). Some psychological factors in parkinsonism. Journal of Neurology, Neurosurgery and Psychiatry 37, 27–31.CrossRefGoogle ScholarPubMed
Jackson, J. A., Free, G. B. M. & Pike, H. V. (1923). The psychic manifestations in paralysis agitans. Archives of Neurology and Psychiatry 10, 680–684.CrossRefGoogle Scholar
Javoy-Agid, F. & Agid, Y. (1980). Is the mesocortical dopaminergic system involved in Parkinson's disease? Neurology 30, 1326–1330.CrossRefGoogle Scholar
Jelliffe, S. E. (1940). The parkinsonian body posture, some considerations of unconscious hostility. Psychoanalytic Review 27, 467–479.Google Scholar
Jouvent, R., Abensour, P., Bonnet, A. M., Widlocher, D., Agid, Y. & Lhermitte, F. (1982). Antiparkinsonian and antidepressant effects of high doses of bromocryptine. Journal of Affective Diseases 5, 141–145.CrossRefGoogle Scholar
Kanzler, M. & Malitz, S. (1972). L-dopa for the treatment of depression. In L-dopa and Behaviour (ed. Malitz, S.), pp. 103–119. Raven Press: New York.Google Scholar
Kuhn, T. S. (1970). The Structure of Scientific Revolutions (2nd edn). University of Chicago Press: Chicago.Google Scholar
Laitinen, L. (1969). Desimipramine in the treatment of Parkinson's disease. Acta Neurologica Scandinavica 45, 109–113.CrossRefGoogle Scholar
Laplane, D., Baulac, M., Widlocher, D. & Dubois, B. (1984). Pure psychic akinesia with bilateral lesions of basal ganglia. Journal of Neurology, Neurosurgery and Psychiatry 47, 377–385.CrossRefGoogle ScholarPubMed
Lebenshon, Z. M. & Jenkins, R. B. (1975). Improvement of parkinsonism in depressed patients treated with ECT. American Journal of Psychiatry 132, 283–285.Google Scholar
Lees, A. J. & Smith, E. (1983). Cognitive deficits in the early stages of Parkinson's disease. Brain 106, 257–270.CrossRefGoogle ScholarPubMed
Lhermitte, J. (1923). Les formes prolongées de l'encéphalite épidémique: forme akinetique, forme akineto-hypertonique, formes psychiatriques prolongées. Le Journal Médical Français 12, 143–153.Google Scholar
Lieberman, A., Dziatolowski, M., Kupersmith, M., Serby, M., Goodchild, A., Korein, J. & Goldstein, M. (1979). Dementia in Parkinson's disease. Annals of Neurology 6, 355–359.CrossRefGoogle Scholar
Mallié, A. H. (1908). Les troubles psychiques chez les parkinsoniens. Thése de Bordeaux.Google Scholar
Marsh, G. G. and Markham, C. H. (1973). Does levodopa alter depression and psychopathology in parkinsonian patients? Journal of Neurology, Neurosurgery and Psychiatry 36, 925–935.CrossRefGoogle Scholar
Matussek, N., Benkert, O., Schneider, K., Otten, H. & Pohlmeir, H. (1970). L-dopa plus decarboxlylase inhibitor in depression. Lancet ii, 660–661.CrossRefGoogle Scholar
Mayer-Gross, W., Slater, E. & Roth, M. (1954). Clinical Psychiatry. Cassell: London.Google Scholar
Mayeux, R., Stern, Y., Rosen, J. & Levanthal, J. (1981). Depression, intellectual impairment and Parkinson's disease. Neurology 31, 645–650.CrossRefGoogle Scholar
Mayeux, R., Stern, Y., Rosen, J. & Benson, D. F. (1983). Is‘subcortical dementia’ a recognisable clinical entity? Annals of Neurology 14, 278–283.CrossRefGoogle Scholar
Mayeux, R., Williams, J. B. W., Stern, Y. & Cote, L. (1984). Depression and Parkinson's disease. In Advances in Neurology, Vol.40 (ed. Hassler, R. G. and Christ, J. F.), pp. 241–250. Raven Press: New York.Google Scholar
McDuff, T. & Sumi, S. M. (1985). Subcortical degeneration in Alzheimer's disease. Neurology 35, 123–126.CrossRefGoogle ScholarPubMed
Mindham, R. H. (1970). Psychiatric symptoms in Parkinsonism. Journal of Neurology, Neurosurgery and Psychiatry 33, 188–191.CrossRefGoogle ScholarPubMed
Mjönes, H. (1949). Paralysis agitans: a clinical and genetic study. Acta Psychiatrica et Neurologica Scandanavica Supplement 54.Google Scholar
Mortimer, J. A., Pirozzolo, F. J., Hansch, E. C. & Webster, D. D. (1982). Relation of motor symptoms to intellectual deficits in Parkinson's disease. Neurology 32, 133–137.CrossRefGoogle Scholar
Naville, F. (1922). Les complications et les sequelles mentales de l'encéphalite épidémique. Encéphale 17, 369–375, 423–436.Google Scholar
Patrick, H. T. & Levy, D. M. (1922). Parkinson's disease: a clinical study of 146 cases. Archives of Neurology and Psychiatry 7, 711–720.CrossRefGoogle Scholar
Pirozzolo, F. J., Hansch, E. C., Mortimer, J. A., Webster, D. D. & Kuskowski, M. A. (1982). Dementia in Parkinson's disease: a neuropsychological analysis. Brain and Cognition 1, 71–83.CrossRefGoogle ScholarPubMed
Praag, H. M.Van, Korf J., Lakke, J. P. W. F. & Schut, T. (1975). Dopamine metabolism in depressions, psychoses, and Parkinson's disease: the problem of the specificity of biological variables in behaviour disorders. Psychological Medicine 5, 138–146.CrossRefGoogle ScholarPubMed
Price, K. S., Farley, I. J. & Hornykiewicz, O. (1978). Neurochemistry of Parkinson's disease: relation between striatal and limbic dopamine. In Advances in Biochemical Psychopharmacology, Vol. 19 (ed. Roberts, P. J., Woodruff, G. N. and Iversen, L. L.), pp.293–300. Raven Press: New York.Google Scholar
Rafal, R. D., Posner, M. I., Walker, J.A. & Friedrich, F. J. (1984). Cognition and the basal ganglia: separating mental and motor components of performance in Parkinson's disease. Brain 107, 1083–1094.CrossRefGoogle ScholarPubMed
Robins, A. H. (1976). Depression in patients with parkinsonism. British Journal of Psychiatry 128, 141–145.CrossRefGoogle ScholarPubMed
Rossor, M. N. (1981). Parkinson's disease and Alzheimer's disease as disorders of the isodendritic core. British Medical Journal 283, 1588–1590.CrossRefGoogle ScholarPubMed
Sigwald, J. (1971). Thérapeutique des syndromes extrapyramidaux par les traitements classiques. In Monoamines, noyaux gris centraux et syndrome de parkinson (ed. de Ajuriaguerra, J. and Gauthier, G.), pp. 369–383. Georg: Geneva.Google Scholar
Steck, H. (1931). Les syndromes mentaux postencéphalitiques. Schweizer Archiv für Neurologie und Psychiatrie 27, 137–173.Google Scholar
Strang, R. R. (1965). Imipramine in treatment of parkinsonism: a double-blind placebo study. British Medical Journal ii, 33–34.CrossRefGoogle Scholar
Talland, G. A. (1963). Manual skill in Parkinson's disease. Geriatrics 18, 613–620.Google ScholarPubMed
Warburton, J. W. (1967). Depressive symptoms in Parkinson patients referred for thalamotomy. Journal of Neurology, Neurosurgery and Psychiatry 30, 368–370.CrossRefGoogle ScholarPubMed
Webster, D. D. (1968). Clinical analysis of the disability in Parkinson's disease. Modern Treatment 5, 257–282.Google Scholar
Wilson, R. S., Kaszniak, A. W., Klawans, H. L. & Garron, D. C. (1980). High speed memory scanning in parkinsonism. Cortex 16, 67–72.CrossRefGoogle ScholarPubMed
Wilson, S. A. K. (1940). Neurology, Vol. I. Arnold: London.Google Scholar
Worster-Drought, C. & Hardcastle, D. N. (1924). A contribution to the psychopathology of residual encephalitis lethargica. Journal of Neurology and Psychopathology 5, 146–150.CrossRefGoogle Scholar
Yudofsky, S. C. (1979). Parkinson's disease, depression and electroconvulsive therapy: a clinical and neurobiologic synthesis. Comprehensive Psychiatry 20, 579–581.CrossRefGoogle ScholarPubMed